Dystrophic epidermolysis bullosa: pathogenesis and clinical features
- PMID: 19945622
- DOI: 10.1016/j.det.2009.10.020
Dystrophic epidermolysis bullosa: pathogenesis and clinical features
Abstract
Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
